Stock Analysis·← Pickers

BIOX

Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. (BIOX) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 41.5, with 0/3 trend checks passing.

Price
$0.36
+0.01 (+1.69%)
Day range
$0.34–$0.36
52wk $0.31–$3.90
Volume
1.8K
Avg
Trend score
0/3
Downtrend
RSI (14)
41.5
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

BIOX with MA50 and MA200

4.393.372.361.340.3308/0110/2701/2304/2007/16
BIOX2025-08-012026-07-16
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.41-15.57% vs price
MA200
$0.92-62.94% vs price
RSI (14)
41.5Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Valuation

BIOX valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

BIOX analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for BIOX

Bioceres Crop Solutions Corp. (BIOX) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.36, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 15.6% and below the 200-day moving average by 62.9%.

Momentum and stretch context

BIOX currently has an RSI reading of 41.5, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing BIOX next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.

Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Federico Trucco
Employees
751
Market cap
$22.8M
Beta
0.42
52-week range
$0.31 – $3.90
Dividend
No
Exchange
NASDAQ
Country
AR
IPO date
22 Mar 2018
ISIN
KYG1117K1141
CUSIP
G1117K114
Company profile data from Financial Modeling Prep. BIOX listed on NASDAQ.
Share dilution

BIOX shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
63.6M
Since Jun 2019
+126.5%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. BIOX28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about BIOX

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.